Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC

Melissa L. Johnson, MD - Harnessing the Poten...

PVI, PEERVIEW INSTITUTE FOR MEDICAL EDUCATIONPVI, PEERVIEW INSTITUTE FOR MEDICAL EDUCATION

Up next

Tuan H. Vu, MD - Generalized Myasthenia Gravis Across Serological Subtypes: Challenges in Diagnosis and Treatment Personalization

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, a ...  Show more

 . 59min 45sec
Pam R. Taub, MD, FACC, FASPC - Managing ASCVD From the Inside Out: Comprehensive Strategies for Getting the Most From Innovative Lipid-Lowering Therapies

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to appl ...  Show more

 . 52min 25sec

Recommended Episodes

Pasi A. Jänne, MD, PhD - Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Go online to PeerView.com/ZGP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The treatment arsenal for non–small cell lung cancer (NSCLC) with and without genomic alterations continues to expand, and novel HER2-, HER3-, and ...  Show more

 . 57min 55sec
Jacob Sands, MD - Assessing the Impact of Therapeutic Advances in SCLC: Instilling New Hope and Moving in Leaps and Bounds Toward Better Outcomes
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Go online to PeerView.com/VDU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Small cell lung cancer (SCLC) is known as an aggressive, rapidly progressing, and challenging thoracic malignancy. After lacking progress for decad ...  Show more

 . 1h 24min
Hussein A. Tawbi, MD, PhD - New Rules for Sequential Care in BRAF-Mutated Melanoma: Rethinking Upfront Selection and Sequencing of Immunotherapy and Targeted Agents in Metastatic Disease
PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast

Go online to PeerView.com/ZBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Treatment advances in metastatic melanoma have been characterized by the use of immunotherapy, including PD-1 and CTLA-4 checkpoint inhibitors, as ...  Show more

 . 1h 2min
Bhavana Pothuri, MD, MS - Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Go online to PeerView.com/KWF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in oncology discusses the role of immune checkpoint inhibitors in the care of patients with recurrent and advanced endo ...  Show more

 . 28min 20sec